In 2010, the export volume of vitamin products was 195,000 tons, an increase of 33.5% year-on-year, and the export amount was 2.3 billion US dollars, an increase of 11.3% year-on-year.
China is the largest producer of vitamins in the world. China produces a wide variety of vitamin products, produces large quantities of food, and has advanced technology. It occupies a pivotal position in the vitamin industry in the world. The main advantages of vitamin C, vitamin E, vitamin A, and vitamin B are at the same time. It is also an export-oriented product.
In 2010, exports showed the following characteristics:
1. The number of exports has increased substantially, export prices of large varieties have fallen, and export prices of small varieties have picked up.
In 2010, the export volume of vitamin products increased by 33.5%, and the average export price decreased by 16.6% year-on-year. This is the first decline in the price of vitamin products for the first time after four consecutive boom years, which is a significant drop, and it is also rare in the entire API market. The main reason is that prices of vitamin C and vitamin E have fallen due to the two pillar products. In 2010, the export volume of vitamin C increased by 46.8%, the unit price of export decreased by 31.3%, the export volume of vitamin E increased by 30.6%, and the unit price of export decreased by 3.3%.
At present, the global vitamin C production plant is concentrated in China except for the DSM Scotland factory. The vast majority of vitamin C produced in China is used for export, accounting for 90% of the international market share, and this part of the market demand for rigidity, demand increases year by year. At the end of 2008, when the US subprime mortgage crisis triggered a global economic downturn, which also had a huge impact on China's exports, Vitamin C exports thrived, export value doubled, export prices increased by 82%, and the vitamin C industry entered a period of high prosperity, and Continue until the full year of 2009.
Second, the export mainstream market is still Europe and the United States and Asia
In 2010, China's vitamin products were exported to 132 countries and regions, an increase of 8 emerging markets over last year. The EU, North America and Asia remain the major markets for my exports, with a share of 90.2%. The year-on-year growth in the number of exports from China's three main markets was more than 27%, which was 39.2% for the EU, 27.4% for North America, and 27.8% for Asia.
In terms of market demand, Asian market demand has maintained a sustained growth for more than ten years, and the export amount has increased by 1.3% compared with last year. After the negative growth of the EU and North America markets in 2009, the number of exports rebounded significantly. At the same time, the export volume of these two markets accounted for 1.1% and 0.1%, respectively, compared with last year, indicating that market demand is recovering.
Third, the industrial concentration is high, and the industrial chain is complete. The proportion of exports from the top ten companies accounts for 60%. At present, vitamin companies in China have achieved production technology advantages and international competitive advantages in several vitamin market segments. Basically, several companies The single vitamin varieties account for most of the global market share, and the industry concentration is very high.
In terms of the nature of export enterprises, the export value of state-owned enterprises, foreign-funded enterprises and private enterprises accounted for 37.6%, 35% and 27.3%, respectively. Among the top ten companies, there are 4 state-owned enterprises, 5 foreign-funded enterprises and 1 private enterprise.
With the improvement of people’s living standards and changes in dietary structure, there is a trend of increasing market demand. The market demand for vitamins mainly comes from the downstream industries such as feed, food, medicine and cosmetology, with an increase of approximately 5% per year. Although the demand for the vitamin market has always been good, the capacity is still limited. With the current situation of domestic raw material medicines, rare varieties are truly in short supply, and most of the products will be quickly supplemented even if short supply is caused due to insufficient supply from manufacturers. In 2010, Vitamin C encountered Waterloo is a good example.
Overcapacity has caused low-price competition among domestic enterprises and has always plagued all API exporters, including vitamins. Domestic APIs are usually long-lasting in the bottom of the valley. Occasionally, the peaks of the peaks are difficult to last, forming a vicious circle. According to statistics, at present, China’s overall exports are approaching the critical line, and the space for the export price competitiveness of China’s exports has been limited. Fortunately, the relevant government departments have begun to intensify their efforts to carry out the work of eliminating excess production capacity.
The vitamin market in 2011 will be affected by changes in the international market, product industry concentration, national policies and regulations, and how dynamic trends will become the focus of attention in the industry.
China is the largest producer of vitamins in the world. China produces a wide variety of vitamin products, produces large quantities of food, and has advanced technology. It occupies a pivotal position in the vitamin industry in the world. The main advantages of vitamin C, vitamin E, vitamin A, and vitamin B are at the same time. It is also an export-oriented product.
In 2010, exports showed the following characteristics:
1. The number of exports has increased substantially, export prices of large varieties have fallen, and export prices of small varieties have picked up.
In 2010, the export volume of vitamin products increased by 33.5%, and the average export price decreased by 16.6% year-on-year. This is the first decline in the price of vitamin products for the first time after four consecutive boom years, which is a significant drop, and it is also rare in the entire API market. The main reason is that prices of vitamin C and vitamin E have fallen due to the two pillar products. In 2010, the export volume of vitamin C increased by 46.8%, the unit price of export decreased by 31.3%, the export volume of vitamin E increased by 30.6%, and the unit price of export decreased by 3.3%.
At present, the global vitamin C production plant is concentrated in China except for the DSM Scotland factory. The vast majority of vitamin C produced in China is used for export, accounting for 90% of the international market share, and this part of the market demand for rigidity, demand increases year by year. At the end of 2008, when the US subprime mortgage crisis triggered a global economic downturn, which also had a huge impact on China's exports, Vitamin C exports thrived, export value doubled, export prices increased by 82%, and the vitamin C industry entered a period of high prosperity, and Continue until the full year of 2009.
Second, the export mainstream market is still Europe and the United States and Asia
In 2010, China's vitamin products were exported to 132 countries and regions, an increase of 8 emerging markets over last year. The EU, North America and Asia remain the major markets for my exports, with a share of 90.2%. The year-on-year growth in the number of exports from China's three main markets was more than 27%, which was 39.2% for the EU, 27.4% for North America, and 27.8% for Asia.
In terms of market demand, Asian market demand has maintained a sustained growth for more than ten years, and the export amount has increased by 1.3% compared with last year. After the negative growth of the EU and North America markets in 2009, the number of exports rebounded significantly. At the same time, the export volume of these two markets accounted for 1.1% and 0.1%, respectively, compared with last year, indicating that market demand is recovering.
Third, the industrial concentration is high, and the industrial chain is complete. The proportion of exports from the top ten companies accounts for 60%. At present, vitamin companies in China have achieved production technology advantages and international competitive advantages in several vitamin market segments. Basically, several companies The single vitamin varieties account for most of the global market share, and the industry concentration is very high.
In terms of the nature of export enterprises, the export value of state-owned enterprises, foreign-funded enterprises and private enterprises accounted for 37.6%, 35% and 27.3%, respectively. Among the top ten companies, there are 4 state-owned enterprises, 5 foreign-funded enterprises and 1 private enterprise.
With the improvement of people’s living standards and changes in dietary structure, there is a trend of increasing market demand. The market demand for vitamins mainly comes from the downstream industries such as feed, food, medicine and cosmetology, with an increase of approximately 5% per year. Although the demand for the vitamin market has always been good, the capacity is still limited. With the current situation of domestic raw material medicines, rare varieties are truly in short supply, and most of the products will be quickly supplemented even if short supply is caused due to insufficient supply from manufacturers. In 2010, Vitamin C encountered Waterloo is a good example.
Overcapacity has caused low-price competition among domestic enterprises and has always plagued all API exporters, including vitamins. Domestic APIs are usually long-lasting in the bottom of the valley. Occasionally, the peaks of the peaks are difficult to last, forming a vicious circle. According to statistics, at present, China’s overall exports are approaching the critical line, and the space for the export price competitiveness of China’s exports has been limited. Fortunately, the relevant government departments have begun to intensify their efforts to carry out the work of eliminating excess production capacity.
The vitamin market in 2011 will be affected by changes in the international market, product industry concentration, national policies and regulations, and how dynamic trends will become the focus of attention in the industry.
Antioxidants Vitamins,Antioxidant Vitamins Tablets,Rubber Antioxygen,Antioxidants Free Radicals
SHANDONG BAISHENG BIOTECHNOLOGY COM , https://www.baishengbioproducts.com